LEADER 03855nam 22005175 450 001 9910300262403321 005 20251116203512.0 010 $a3-319-51198-X 024 7 $a10.1007/978-3-319-51198-6 035 $a(CKB)4100000006674612 035 $a(MiAaPQ)EBC5525856 035 $a(DE-He213)978-3-319-51198-6 035 $a(PPN)230537952 035 $a(EXLCZ)994100000006674612 100 $a20180925d2018 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aAlternate Fractionation in Radiotherapy $eParadigm Change /$fedited by Mark Trombetta, Jean-Philippe Pignol, Paolo Montemaggi, Luther W. Brady 205 $a1st ed. 2018. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2018. 215 $a1 online resource (428 pages) 225 1 $aRadiation Oncology 311 08$a3-319-51197-1 327 $aDedication -- 1 Introduction -- 2 Historical Development of Alternate Fractionation Schema -- 3 Radiobiology of Alternate Fractionation -- 4 Technological advances enabling Alternate Fractionation -- a Beam delivery -- b Imaging Technology -- c Treatment Planning -- 5 Workflow and Quality Assurance in Alternate Fractionation -- 6 The Future of Alternate Fractionation -- Part I DISEASE SITE SPECIFIC TOPICS -- 7 Central Nervous System Cancer -- 8 Head and Neck Cancer -- 9 Breast Cancer -- 10 Lung Cancer -- 11 Upper Gastrointestinal Cancer: Esophagus and Stomach -- 12 Upper Gastrointestinal Cancer: Hepatobiliary and Pancreas -- 13 Lower Gastrointestinal Cancer -- 14 Genitourinary Cancer -- 15 Gynecologic Cancer -- 16 Skin Cancer and Melanoma -- 17 Sarcoma -- 18 Lymphoma and Non-Solid Tumors -- 19 Benign Disease -- 20 Index. 330 $aThis book, written by leading international experts, describes alternate fractionation strategies in which technology-driven precise targeting and dosing allow for improved conformance and decreased volumes, with concordant lessening of toxicity, reduction in treatment time, and lower overall health care expense. The aim is to provide the advanced clinician with an up-to-date evidence-based reference that will assist in the delivery of enhanced patient care in daily practice. Traditional multi-week fractionation schedules were established at a time when the inclusion of relatively large amounts of normal tissue was unavoidable owing to the lack of accurate target localization during treatment. Such schedules are time and resource consuming, difficult for patients, and expensive. Nevertheless, acceptance of alternate fractionation strategies has been slow in some countries. The paradigm is, however, changing as evidence accumulates to demonstrate improved local control, equivalence of tolerance, or both. In documenting these alternate strategies, this book will be of value for radiation oncologists, medical physicists, and oncologists worldwide. 410 0$aRadiation Oncology 606 $aRadiotherapy 606 $aOncology 606 $aRadiotherapy$3https://scigraph.springernature.com/ontologies/product-market-codes/H29056 606 $aOncology$3https://scigraph.springernature.com/ontologies/product-market-codes/H33160 615 0$aRadiotherapy. 615 0$aOncology. 615 14$aRadiotherapy. 615 24$aOncology. 676 $a615.842 702 $aTrombetta$b Mark$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aPignol$b Jean-Philippe$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aMontemaggi$b Paolo$4edt$4http://id.loc.gov/vocabulary/relators/edt 702 $aBrady$b Luther W$4edt$4http://id.loc.gov/vocabulary/relators/edt 906 $aBOOK 912 $a9910300262403321 996 $aAlternate Fractionation in Radiotherapy$91742380 997 $aUNINA